{"Symbol": "ASMB", "AssetType": "Common Stock", "Name": "Assembly Biosciences Inc", "Description": "Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California.", "CIK": "1426800", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "TWO TOWER PLACE, SOUTH SAN FRANCISCO, CA, UNITED STATES, 94080", "OfficialSite": "https://www.assemblybio.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "421685000", "EBITDA": "-43320000", "PERatio": "None", "PEGRatio": "0", "BookValue": "11.55", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-4.6", "RevenuePerShareTTM": "4.319", "ProfitMargin": "-1.036", "OperatingMarginTTM": "-1.009", "ReturnOnAssetsTTM": "-0.16", "ReturnOnEquityTTM": "-0.369", "RevenueTTM": "37191000", "GrossProfitTTM": "-24652000", "DilutedEPSTTM": "-4.6", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0.576", "AnalystTargetPrice": "47.75", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "4", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "11.34", "PriceToBookRatio": "2.308", "EVToRevenue": "5.16", "EVToEBITDA": "0.424", "Beta": "1.15", "52WeekHigh": "39.71", "52WeekLow": "7.75", "50DayMovingAverage": "30.86", "200DayMovingAverage": "24.72", "SharesOutstanding": "15817100", "SharesFloat": "7458300", "PercentInsiders": "32.299", "PercentInstitutions": "54.154", "DividendDate": "None", "ExDividendDate": "None"}